Rite Aid (RAD) Stock Price, News & Analysis

Company Overview

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and seasonal merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. In addition, it offers its products through online retail site. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.39 to $1.89
• 52-Week Range: N/A
• Volume: 5,426 shs
• Average Volume: 4.16 million shs
• Market Capitalization: $34.71 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Rite Aid Stock Analysis - MarketRank™

Rite Aid scored higher than 1% of companies evaluated by MarketBeat, and ranked 217th out of 217 stocks in the retail/wholesale sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Rite Aid.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Rite Aid are expected to grow in the coming year, from ($4.75) to ($3.35) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Rite Aid is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Rite Aid is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for RAD.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Rite Aid does not currently pay a dividend.

Dividend Growth

Rite Aid does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 1.9 / 5
• Environmental Score: -1.85

Short Interest

There is no current short interest data available for RAD.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Rite Aid this week, compared to 5 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Rite Aid insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.58% of the stock of Rite Aid is held by insiders.

Percentage Held by Institutions

Only 34.47% of the stock of Rite Aid is held by institutions.

RAD Stock Analysis - Frequently Asked Questions

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) announced its quarterly earnings results on Thursday, April, 20th. The company reported ($1.24) EPS for the quarter, missing the consensus estimate of ($0.77) by $0.47. Rite Aid's revenue for the quarter was up .5% on a year-over-year basis.

When did Rite Aid's stock split?

Shares of Rite Aid reverse split on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 19th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Does Rite Aid have any subsidiaries?

Rite Aid subsidiaries include these companies: Bartell Drugs, Envision Pharmaceutical, RediClinic, Health Dialog, Edgehill Drugs, PCS Health Systems, Harco, and more.

What other stocks do shareholders of Rite Aid own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Rite Aid investors own include BMO Capital Markets (), Stifel Nicolaus (), Wunderlich (), Standpoint Research (), Duncan Williams (), Soleil Securities () and Sterne Agee CRT ().

Company Calendar

• Last Earnings: 4/20/2023
• Today: 11/12/2024
• Fiscal Year End: 2/28/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Retail/Wholesale
• Industry: Drug stores & proprietary stores
• Sub-Industry: Drug Retail
• Current Symbol: NYSE:RAD
• CUSIP: 76775410
• CIK: 84129
• Web: www.riteaid.com
• Phone: (717) 761-2633
• Fax: 717-975-5871
• Employees: 47,000
• Year Founded: 1968

Profitability

• EPS (Most Recent Fiscal Year): ($17.25)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-749,940,000.00
• Net Margins: -3.99%
• Pretax Margin: -4.02%
• Return on Equity: N/A
• Return on Assets: -1.90%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.32
• Quick Ratio: 0.61

Sales & Book Value

• Annual Sales: $24.09 billion
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 0.36
• Book Value: ($11.35) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 56,700,000
• Free Float: 55,800,000
• Market Cap: $34.71 million
• Optionable: Optionable
• Beta: 1.25